Valeo Pharma Inc. at its annual general meeting held on April 27, 2022, announced the appointment of Marc Léger as director of the Company. Mr. Léger is a seasoned pharmaceutical executive with pan-Canadian and U.S. experience in both the prescription pharmaceutical and consumer healthcare businesses. He has extensive experience in building and leading organizations and has an excellent track record of developing best in class brands.